NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









RhythmScience Inc.

RhythmScience Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.rhythm360.io/

Last Round

Series A

Mar 24, 2023

Total Funding Raised

$6M

Company Overview

RhythmScience Inc. is a health-tech company that provides a platform, Rhythm360, which analyzes cardiac data to improve the management of hypertension, heart failure, and rhythm disorders.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Telemedicine, Healthcare Analytics, Health IoT, EHR & EMR

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

cardiac data managementremote cardiac monitoringvendor-neutral platformremote patient monitoringRPMEHR integrationcardiology softwareCIED managementCPT code automationcardiology workflow automationAI alert triageheart failure managementhealth data aggregationdigital health platformhealth IoTSOC 2 certified

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RhythmScience Inc. Comparables

Compare RhythmScience Inc. with similar companies based on industry and business-model similarity.

RhythmScience Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PaceMate
91%
Vector Remote Care
91%
Octagos Health
86%

RhythmScience Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 24, 2023
AcceleratorJan 25, 2022

RhythmScience Inc. Investors

Notable investors and investment history

RhythmScience Inc. investors
InvestorRounds
TenOneTen VenturesSeries A
Cedars Sinai Health VenturesSeries A
OCA VenturesSeries A
MATTERAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 21, 2023

    Grew 17% QoQ, from 35 to 41 employees.

  • Oct 28, 2023

    Grew 25% QoQ, from 32 to 40 employees.

RhythmScience Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RhythmScience Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RhythmScience Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range52
Year Founded2019
Last FundingMar 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.